Home / News & Campaigns / Latest News / NICE approval of SIRT

News & Campaigns

NICE approval of SIRT

Wednesday, August 03, 2011

The National Institute for Health and Clinical Excellence (NICE) has announced that it has produced guidance to support the routine use of SIRT (Selective Internal Radiation Therapy)for the treatment of patients with liver tumours resulting from bowel cancer.

This welcome decision culminates an extensive dialogue between patients, patient groups, clinical experts and parliamentarians.

SIRT is used for the treatment of inoperable liver tumours and involves injecting millions of tiny radioactive microspheres into the liver via the hepatic artery.